We’re excited and deeply grateful to share that Virtue 340B has been named “Top 340B Consulting Services 2026” by Healthcare Business Review, for the second
The Pharmacy500 is awarded to 500 supply chain businesses and associations that have made a significant impact on dispensing pharmacies in the U.S. over the
A comprehensive, no-cost resource for covered entities preparing for 2026. The Inflation Reduction Act’s (IRA) Maximum Fair Price (MFP) requirements and HRSA’s 340B Rebate Model
In recent weeks, PhRMA has amplified a new messaging campaign, including ads and videos such as “End Middlemen Markups. Put American Patients First.” These pieces
Have you ever received a good-faith inquiry from a manufacturer and wondered how to respond? In the latest episode of Katy’s 340B Compass, Katy F
As the 340B rebate pilot approaches its January 2026 launch, one of the most debated questions is whether covered entities should be required to submit
The 340B system is broken — and it’s not because anyone’s doing the wrong thing. In this new episode of Katy’s 340B Compass, Katy F
The alarm sounds at 5:30 AM. A hospital pharmacy director jolts awake to the same stomach-churning realization: HRSA auditors arrive next week. Thousands of prescriptions,
It’s recertification time—and HRSA just dropped a pilot rebate policy. In Episode 7 of Katy’s 340B Compass, Katy breaks down: Watch now on YouTube, and
The 340B landscape continues to shift—policy debates, manufacturer restrictions, and operational pressures have left many covered entities questioning whether their programs are positioned for long-term
